News from NORD

Neuroendocrine Tumor Research Foundation Announces Change of Leadership

Publish date: November 2, 2017

 

After six successful years, Ron Hollander will be stepping down as executive director of the Neuroendocrine Tumor Research Foundation. His successor will be Elyse Gellerman. More.

Recommended Reading

Vestibular Disorders Association Celebrates Balance Awareness Week
MDedge Endocrinology
Biologic may bring relief for children and adults with XLH syndrome
MDedge Endocrinology
Nominate a Colleague or Patient for a NORD Rare Impact Award
MDedge Endocrinology
Orphan Drugs Are Not Driving Up the Cost of Health Care, According to New Study
MDedge Endocrinology
NORD Call for Abstracts Reopened
MDedge Endocrinology
NORD Board Chair to Moderate Social Security Administration Forum
MDedge Endocrinology
NORD Supports Orphan Drug Tax Credit
MDedge Endocrinology
Small Kansas Town Turns Night Into Day for Boy With Rare Disease
MDedge Endocrinology
Adrenal Insufficiency United (AIU) Conference
MDedge Endocrinology
American Partnership for Eosinophilic Disorders (APFED) Pilot Grants
MDedge Endocrinology